Two closely watched copyright cases over the songs “Blurred Lines” and “Stairway to Heaven,” both set for rulings next year by the Ninth Circuit, are quietly linked by a common question: What music can jurors actually hear?
The U.S. District Court for the District of New Jersey has ruled that Ranbaxy Laboratories’ generic version of GlaxoSmithKline's antibiotic Ceftin does not infringe patents held by Glaxo.
International law firm Shaw Pittman is actively looking for intellectual property attorneys to fill its planned office in the Silicon Valley area, the firm’s practice group leader says.
Chip makers Ramtron International Corp. and National Semiconductor Corp. have settled a U.S. patent interference dispute that dates back to 1991 in a deal that includes payments of $2.5 million to National Semi, Ramtron said Wednesday.
Seattle-based intellectual property specialty firm Christensen O'Connor Johnson Kindness PLLC has hired two patent agents and an associate, the firm said.
A federal district court in Western Kentucky is hearing arguments this week in a trademark dispute between two bourbon makers.
Japanese electronics giant Fujitsu has filed lawsuits in Tokyo and Los Angeles against two units of South Korea's Samsung Electronics, alleging infringement of patents related to plasma display panels, the company said Wednesday.
The U.S. Court of Appeals for the Federal Circuit has upheld Genentech's legal victory in a $1 billion patent battle with biotechnology rival Chiron.
A three-judge panel of the U.S. Trademark Trial and Appeal Board has unanimously ruled that the terms "Realtor" and "Realtors" are not generic.
A coalition of U.N. agencies and charitable organizations including former U.S. President Bill Clinton’s foundation unveiled a plan to buy and distribute generic AIDS drugs to developing countries at deep discounts.
Activists for the environmental pressure group Greenpeace blocked the entrance to the European Patent Office in Munich on Monday in a protest against a patent for breeding human embryos.
The U.S. Supreme Court has refused to hear a trademark dispute between the heir to the Skippy comic strip and the maker of the peanut butter with the same name.
International law firm Shaw Pittman is planning to open new offices in Silicon Valley and Taiwan in an effort to beef up its intellectual property practice.
AstraZeneca has filed a patent infringement lawsuit in the U.S. District Court for the District of Delaware against Eon Labs based on the generic maker’s plan to make a copycat version of the hypertension drug Toprol-XL.
Cisco Systems Inc has extended the suspension of its copyright lawsuit against rival Huawei Technologies by an additional six months.
Diomed has sued rival Total Vein Solutions for alleged infringement of its patent for endovascular laser treatments of varicose veins.
German drug maker Altana said it will take legal steps against a patent challenge for its ulcer drug pantoprazole from a generic competitor in the U.S., the company said in a statement on Monday.
The U.S. Federal Trade Commission has filed an amicus curiae brief with the U.S. Court of Appeals for the Federal Circuit, supporting Teva Pharmaceutical Industries Ltd. in its litigation against Pfizer over its right to make a generic version of the top-selling antidepressant Zoloft.
Israel plans to make concessions to the U.S. on intellectual property issues in the pharmaceutical industry, a senior official told a business newspaper.
Software giant Microsoft and archrival Sun Microsystems have signed a broad settlement agreement that includes the resolution of long-standing patent litigation, the two companies said in a surprise announcement Friday.
The European Patent Office has invalidated a patent for drug-coated stents, which has been at the center of a dispute between medical device makers Medinol and Boston Scientific in the Netherlands.